Metagenomics Market - A Global and Regional Analysis: Focus on Type, Workflow, Technology, Application, and Region - Analysis and Forecast, 2024-2033

Global Metagenomics Market Industry Overview

The global metagenomics market was valued at $1,808.0 million in 2023 and is expected to reach $9,286.1 million by 2033, growing at a CAGR of 17.90% between 2024 and 2033. The metagenomics market has experienced significant growth as it explores the vast array of microbial communities that cannot be cultured in the lab. Metagenomics, a field that employs genomic analysis tools to study microbial genomes directly from environmental samples, has revolutionized our understanding of microbial diversity and functionality. This market is driven by advancements in sequencing technologies, increasing awareness of microbial influence on health, and the application of metagenomics in various sectors such as agriculture, biotechnology, and environmental restoration. The surge in demand for personalized medicine and the need for novel antibiotics and enzymes are further propelling the market forward, making metagenomics an invaluable resource in both scientific research and commercial applications.

Market Introduction

The global metagenomics market is rapidly expanding, fueled by the convergence of technological advancements in genetic sequencing and a growing recognition of the microbial world's impact on health and the environment. This market leverages the power of metagenomics to decode genetic material from microbial communities directly extracted from environmental samples, bypassing traditional culturing methods. Key drivers include the rising demand for improved diagnostic techniques, the exploration of microbial functions in bioremediation, and the agricultural sector's push for sustainable practices. With its applications spanning from medical research to environmental science and agriculture, the global metagenomics market is poised to address some of the most pressing challenges in healthcare, sustainability, and bio innovation. The market includes segments such as by product type, by workflow, by application, by technology, and by region.

Industrial Impact

The industrial impact of the global metagenomics market is profound and multifaceted, influencing a variety of sectors. In healthcare, metagenomics is revolutionizing the development of novel diagnostics and therapeutics, particularly in understanding the human microbiome's role in disease and health. This has led to the creation of more targeted treatments and the identification of new drug candidates. In the environmental sector, metagenomics assists in monitoring biodiversity and the health of ecosystems, crucial for environmental conservation and remediation efforts. Additionally, in agriculture, it enhances soil health analysis and crop yield predictions, contributing to sustainable farming practices. The biotechnology field also benefits significantly, as metagenomics facilitates enzyme discovery and the development of new biochemical processes, which are essential for industrial bioprocessing and bioenergy production. Overall, the expansion of metagenomics is driving innovation across these industries, leading to more sustainable practices and improved health outcomes.

Market Segmentation:

Segmentation 1: by Product Type

• Consumables
• Instruments
• Services and Software

Consumables Segment to Dominate the Metagenomics Market (by Product Type)

The consumables segment is poised to dominate the metagenomics market by product type, reflecting its critical role in the array of metagenomic workflows and processes. Consumables, including reagents, kits, and other disposable components, are essential for extracting, sequencing, and analysing genetic material from environmental samples. Their high usage rate and the need for regular replenishment drive their demand, making them a continual source of revenue for companies in the field. The segment's growth is bolstered by the increasing number of metagenomic studies aimed at understanding microbial diversity and function across various applications in healthcare, agriculture, and environmental science. As next generation sequencing technologies advance and become more accessible, the demand for these consumables is expected to surge, further cementing their leading position in the market.

Segmentation 2: by Workflow

• Sample Preparation (Pre-Sequencing)
• Sequencing
• Data Analysis

Sample Preparation (Pre-Sequencing) Segment to Dominate the Metagenomics Market (by Workflow)

The sample preparation (pre-sequencing) segment is expected to dominate the metagenomics market by workflow, underscoring its pivotal role in the success of metagenomic analyses. This segment involves critical steps such as the extraction of DNA from diverse and often challenging environmental samples, which is fundamental to the integrity of the subsequent sequencing and analysis. The precision and quality of sample preparation directly influence the accuracy and reliability of metagenomics data, making it a crucial area of investment for researchers and companies alike. With the expanding scope of metagenomics applications in complex environments like oceanic and soil microbiomes, the demand for robust and efficient pre-sequencing technologies is increasing. This trend is driving innovations and improvements in sample preparation kits and protocols, ensuring that this segment maintains its dominant position in the workflow of the metagenomics market.

Segmentation 3: by Technology

• Capillary Electrophoresis
• Single Molecule Sequencing
• Sequencing by Synthesis
• Sequencing by Ligation
• Nanopore Sequencing
• Other Technologies

Sequencing by Synthesis Segment to Dominate the Metagenomics Market (by Formulation)

The sequencing by synthesis segment is poised to lead the metagenomics market by formulation, indicating its prominence in the field. This segment involves the use of sequencing technologies that rely on the synthesis of complementary DNA strands during the sequencing process. Its dominance underscores its effectiveness in generating high-quality sequencing data from metagenomic samples. As the demand for accurate and efficient sequencing methods continues to rise, particularly in the exploration of microbial communities across diverse environments, the sequencing by synthesis segment is expected to maintain its predominant position within the metagenomics market.

Segmentation 4: by Application

• Clinical Diagnostics
• Industrial Applications
• Research Applications

Research Application Segment to Dominate the Metagenomics Market (by Application)

The research application segment is anticipated to lead the metagenomics market by application, highlighting its significance in advancing scientific understanding across various fields. This segment encompasses a wide range of research, including studies aimed at elucidating the diversity, function, and interactions of microbial communities in different environments. Metagenomics plays a pivotal role in addressing critical research questions in areas such as human health, environmental conservation, agriculture, and biotechnology. As the demand for comprehensive insights into microbial ecosystems continues to grow, driven by the need for innovative solutions to global challenges, the Research Application segment is expected to maintain its dominance in driving advancements and discoveries in the metagenomics market.

Segmentation 5: by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe
• Asia-Pacific
  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest-of-Latin America
• Middle East and Africa
  • South Africa
  • U.A.E.
  • Rest-of-Middle East and Africa

The North America segment is positioned to hold a significant share in the global metagenomics market for several compelling reasons. The North America segment is poised to command a substantial share of the global metagenomics market due to various compelling factors. With a robust infrastructure for research and development, coupled with significant investments in biotechnology and life sciences, North America stands at the forefront of metagenomics innovation. Moreover, the region boasts a concentration of leading biotechnology and pharmaceutical companies, fostering collaborations and partnerships that drive advancements in metagenomic technologies and applications. Additionally, the growing awareness of the role of microbial communities in human health and the environment has spurred increased research funding and initiatives in North America, further propelling the growth of the metagenomics market in the region.

Recent Developments in the Metagenomics Market

• In January 2024, Eurofins Genomics announced the establishment of a newly certified sequencing laboratory in Bothell, Washington, catering to the larger Seattle region. Utilizing the Oxford Nanopore sequencing platform and its nearby location, the facility ensures results are delivered within 12 hours of sample collection. The company has established partnerships with 30 laboratories in Seattle and conducts daily sample collection and sequencing for the biotech hub.
• In February 2024, MGI Tech Co., Ltd. Tech Co., Ltd. revealed a collaboration agreement with MetaGenoPolis, a division of the esteemed National Research Institute for Agriculture, Food and the Environment in France. This collaboration comes after MetaGenoPolis was chosen as a core lab for the Million Microbiomes from Humans Project.
• In June 2023, Eurofins Genomics U.S. introduces the express oxford nanopore sequencing service, providing same-day results.
• In March 2023, Macrogen Inc. announced the launch of NovaSeq X Plus to Korea, marking the system's debut in the Asian market.

Demand - Drivers, Challenges, and Opportunities

Market Demand Drivers:

Significant Reduction in Sequencing Costs Leading to an Increase In the Number of Metagenomics Studies: One of the most notable drivers in the global metagenomics market is the substantial reduction in the costs associated with sequencing This decrease in pricing has made sequencing more accessible across various sectors including healthcare, research, and personalized medicine. Consequently, there has been a reported rise in the volume of metagenomics research and its application in clinical settings for the analysis of genetic sequences.

Market Challenges:

Challenge of Securely Storing Vast Volumes of Sequenced Data: A key restraint in the global metagenomics market is the challenge of securely storing the vast volumes of sequenced data. With significant growth driven by technological advances, reduced sequencing costs, and governmental support for genomic applications in personalized medicine, there's been a surge in genomic testing and, consequently, data generation.

Market Opportunities:

Opportunity for Metagenomics in Microplastic Remediation: Metagenomics plays a crucial role in uncovering new microbial communities for tackling the issue of microplastic pollution. Microplastics, tiny plastic fragments posing significant environmental challenges, are increasingly found across diverse ecosystems due to human activities. Their enduring nature and the risk they pose to living organisms through biomagnification necessitate the development of effective remediation techniques.

How can this Report add value to an Organization?

Product/Innovation Strategy: The global metagenomics market has been segmented based on various categories, such as product type, workflow, technology, application, and region.

Growth/Marketing Strategy: Partnerships, alliances, and business expansions together accounted for the maximum number of key developments of the total developments in the global metagenomics market between January 2021 and April 2024.

Competitive Strategy: Key players are investing heavily in research and development to enhance their product portfolios and develop cutting-edge technologies for sample preparation, sequencing, and analysis. Strategic collaborations with academic institutions, research organizations, and industry partners are also key, facilitating access to diverse datasets and expertise. Furthermore, companies are focusing on expanding their market presence through geographic expansion and strategic acquisitions to capitalize on emerging opportunities and consolidate their market position.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• The base year considered for the calculation of the market size is 2023. A historical year analysis has been done for the period FY2019-FY2022. The market size has been estimated for FY2023 and projected for the period FY2024-FY2033.
• The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of metagenomics instruments, consumables, and services.
• The market contribution of metagenomics is anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
• Revenues of the companies have been referenced from their annual reports for FY2022 and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
• The market has been mapped based on the available PMS and menstrual health supplement solutions. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in metagenomics, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

• validation and triangulation of all the numbers and graphs
• validation of the report's segmentation and key qualitative findings
• understanding the competitive landscape and business model
• current and proposed production values of a product by market players
• validation of the numbers of the different segments of the market in focus
• percentage split of individual markets for regional analysis

Secondary Research:

Open Sources

• Certified publications, articles from recognized authors, white papers, directories, and major databases, among others.
• Annual reports, SEC filings, and investor presentations of the leading market players
• Company websites and detailed study of their product portfolio
• Gold standard magazines, journals, white papers, press releases, and news articles
• Paid databases

The key data points taken from the secondary sources include:

• segmentations and percentage shares
• data for market value
• key industry trends of the top players of the market
• qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

The research applications is leading the market and captured around 55.07% of the market's presence as of 2023. Clinical Diagnostics, on the other hand, accounted for approximately 27.52% of the market presence in 2023.

Some prominent names established in this market are:

• BGI Genomics
• Eurofins Scientific
• Illumina, Inc.
• MGI Tech Co., Ltd.
• Oxford Nanopore Technologies plc
• Pacific Biosciences of California, Inc.
• Macrogen, Inc.
• QIAGEN N.V.
• Revvity, Inc. (PerkinElmer Inc.)
• Thermo Fisher Scientific, Inc.